StemCell Institute Inc.JP:7096
Market cap
¥8B
P/E ratio
24.8x
| 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 35 | 32 | 33 | 97 | 105 | 121 | 128 |
| Cash from operations | 391 | 668 | 239 | 469 | 100 | 335 | 468 |
| Capital expenditures | -29 | -59 | -401 | -181 | -56 | -183 | -478 |
| Cash from investing | -184 | -108 | -520 | 404 | -285 | -812 | -259 |
| Payments for dividends | - | - | - | - | - | - | -256 |
| Repurchases of common stock | - | - | - | - | -0 | - | -94 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | 510 |
| Repayments of term debt | - | - | - | - | - | - | -10 |
| Cash from financing | - | - | - | 644 | -1 | -1 | 147 |